Efficacy and safety of follitropin alpha biosimilars compared to their reference product: a Meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of follitropin alpha biosimilars compared to their reference product: a Meta-analysis

Published:2020-07-11 Issue:5 Volume:37 Page:406-414
ISSN:0951-3590
Container-title:Gynecological Endocrinology
language:en
Short-container-title:Gynecological Endocrinology

Author:

Budani Maria Cristina¹,Fensore Stefania²,Di Marzio Marco²,Tiboni Gian Mario³

Affiliation:

1. Department of Medicine and Aging Sciences, University “G. d’Annunzio” Chieti-Pescara, Chieti, Italy

2. Department of Philosophical, Pedagogical and Economic-Quantitative Sciences, University “G. d'Annunzio” Chieti-Pescara, Pescara, Italy

3. Department of Medical, Oral and Biotechnological Sciences, University “G. d’Annunzio” Chieti-Pescara, Chieti, Italy

Publisher

Informa UK Limited

Subject

Obstetrics and Gynaecology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.1080/09513590.2020.1792437

Reference27 articles.

1. EMA (European Medical Agency). Committee for Human Medicinal Products (CHMP) European Medicines Agency procedural advice for users of the centralised procedure for similar biological medicinal products applications. EMA/940451/2011; [cited 2020 July 7]. Available from: https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/european-medicines-agency-procedural-advice-users-centralised-procedure-similar-biological-medicinal_en-0.pdf.

3. The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization

4. Molecular regulation of follicle-stimulating hormone synthesis, secretion and action

5. The Development of Gonadotropins for Clinical Use in the Treatment of Infertility

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gonadotropins in assisted reproductive technology programs: A review;Gynecology;2024-05-09

2. Updated clinical and economic analysis of using follitropin alfa in combination with assisted reproductive technologies in 2022;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2023-04-21

3. An updated meta-analysis comparing the efficacy and safety of biosimilar medicinal products to the original follitropin alfa;Minerva Obstetrics and Gynecology;2022-12

4. Comparative Assessment of the Structural Features of Originator Recombinant Human Follitropin Alfa Versus Recombinant Human Follitropin Alfa Biosimilar Preparations Approved in Non-European Regions;International Journal of Molecular Sciences;2022-06-17

5. Pharmacoeconomic analysis of the application of follitropin alfa in combination with assisted reproductive technologies;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2022-04-14